Avalo Therapeutics, Inc.2024财年第三财季实现净利润23.04百万美元,同比增加540.54%

市场透视
14 Nov 2024

11月14日,Avalo Therapeutics, Inc.(AVTX.US)公布财报,公告显示公司2024财年第三财季净利润为23.04百万美元,同比增加540.54%;其中营业收入为249000.00美元,同比增加5.51%,每股基本收益为0.98美元。从资产负债表来看,Avalo Therapeutics, Inc.(AVTX.US)总负债75.72百万美元,其中短期债务550000.00...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10